CD8A and COVID-19: Finally, we observed an attenuation in the percentage of CD8+TM in COVID-19(+) BALFs, which was most apparent in severe patients (Fig. 1i, l), corroborating the impaired memory cell abundance found in PBMCs (Fig. 1d, g).